Successful management of a young patient with endometroid ovarian carcinoma with positive immuno-histochemistry

Authors

  • Chiranjeev Shetty Department of Obstetrics and Gynecology, Dr. D. Y. Patil Hospital Nerul, Navi Mumbai, Maharashtra, India
  • Meena Satia Department of Obstetrics and Gynecology, Dr. D. Y. Patil Hospital Nerul, Navi Mumbai, Maharashtra, India
  • V. Bhadhwar Department of Obstetrics and Gynecology, Dr. D. Y. Patil Hospital Nerul, Navi Mumbai, Maharashtra, India
  • Nilofer Yelurkar Department of Obstetrics and Gynecology, Dr. D. Y. Patil Hospital Nerul, Navi Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20251775

Keywords:

Endometrioid ovarian carcinoma, Endometriosis-associated ovarian cancer, Immunohistochemistry, Estrogen receptor, Radiological evaluation, Staging laparotomy

Abstract

Ovarian cancer is overall a disease of postmenopausal women although, in about 12% of cases, it may develop during child bearing age. This estimate includes numerous women with borderline and non-epithelial tumours typically presenting during child bearing age group. Although there are several case reports of Endometriosis-associated ovarian cancer (EAOC) at a young age, the exact age distribution of EAOC diagnosis is still not well- expounded. Presenting here with a young patient with ovarian malignancy with positive immuno-histochemistry for both oestrogen and progesterone receptor.

Metrics

Metrics Loading ...

References

Kurman RJ, Shih IM. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. American J Pathol. 2016;186(4):733-47. DOI: https://doi.org/10.1016/j.ajpath.2015.11.011

Richani D, Gilchrist RB. The epidermal growth factor network: role in oocyte growth, maturation and developmental competence. Human Reprod. 2018;24(1):1-4. DOI: https://doi.org/10.1093/humupd/dmx029

Saavalainen L, Lassus H, But A, Tiitinen A, Härkki P, Gissler M, et al. Risk of gynecologic cancer according to the type of endometriosis. Obst Gynecol. 2018;131(6):1095-102. DOI: https://doi.org/10.1097/AOG.0000000000002624

Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. New England J Med. 2010;363(16):1532-43. DOI: https://doi.org/10.1056/NEJMoa1008433

Westhoff GL, Chen Y, Teng NN. Targeting FOXM1 improves cytotoxicity of paclitaxel and cisplatinum in platinum-resistant ovarian cancer. International J Gynecol Cancer. 2017;27(8):1602-9. DOI: https://doi.org/10.1097/IGC.0000000000001063

Bigelow AM, Crane SS, Khoury FR, Clark JM. Catheter ablation of supraventricular tachycardia without fluoroscopy during pregnancy. Obst Gynecol. 2015;125(6):1338-41. DOI: https://doi.org/10.1097/AOG.0000000000000601

Kvaskoff M, Mahamat-Saleh Y, Farland LV, Shigesi N, Terry KL, Harris HR, et al. Endometriosis and cancer: a systematic review and meta-analysis. Human Reprod. 2021;27(2):393-420. DOI: https://doi.org/10.1093/humupd/dmaa045

Mikami Y. Endometriosis-related ovarian neoplasms: pathogenesis and histopathologic features. Diag Histopathol. 2014;20(9):357-63. DOI: https://doi.org/10.1016/j.mpdhp.2014.07.002

Li DP, Du C, Zhang ZM, Li GXBreastfeeding and ovarian cancer risk: a systematic review and meta-analysis of 40 epidemiological studies. Asian Pacific J Cancer Preven. 2014;15(12):4829-37. DOI: https://doi.org/10.7314/APJCP.2014.15.12.4829

Zhang X, Li M, Tang Z, Li X, Song T. Differentiation between endometriosis-associated ovarian cancers and non-endometriosis-associated ovarian cancers based on magnetic resonance imaging. Br J Radiol. 2021;94(1125):1441. DOI: https://doi.org/10.1259/bjr.20201441

Umeoka S, Koyama T, Togashi K, Kobayashi H, Akuta K. Vascular dilatation in the pelvis: identification with CT and MR imaging. Radiographics. 2004;24(1):193-208. DOI: https://doi.org/10.1148/rg.241035061

Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics. 2005;25(5):1357-68. DOI: https://doi.org/10.1148/rg.255045122

Zhu C, Xu Z, Zhang T, Qian L, Xiao W, Wei H, et al. Updates of pathogenesis, diagnostic and therapeutic perspectives for ovarian clear cell carcinoma. J Cancer. 2021;12(8):2295. DOI: https://doi.org/10.7150/jca.53395

Gong E, Pauly JM, Wintermark M, Zaharchuk G. Deep learning enables reduced gadolinium dose for contrast‐enhanced brain MRI. J Magn Reson Imag. 2018;48(2):330-40. DOI: https://doi.org/10.1002/jmri.25970

Gałczyński K, Chauvet P, Canis M, Bourdel N. Laparoscopic extraperitoneal lumboaortic lymphadenectomy in 10 steps–Let's make it easier. Gynecol Oncol. 2016;143(2):448-9. DOI: https://doi.org/10.1016/j.ygyno.2016.08.326

Medeiros LR, Rosa MI, Silva BR, Reis ME, Simon CS, Dondossola ER, da Cunha Filho JS. Accuracy of magnetic resonance in deeply infiltrating endometriosis: a systematic review and meta-analysis. Arch Gynecol Obst. 2015;291:611-21. DOI: https://doi.org/10.1007/s00404-014-3470-7

Downloads

Published

2025-06-17

How to Cite

Shetty, C., Satia, M., Bhadhwar, V., & Yelurkar, N. (2025). Successful management of a young patient with endometroid ovarian carcinoma with positive immuno-histochemistry. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 14(7), 2369–2372. https://doi.org/10.18203/2320-1770.ijrcog20251775

Issue

Section

Case Reports